Manhattan Scientifics Inc (MHTX) financial statements (2021 and earlier)

Company profile

Business Address 244 FIFTH AVENUE
NEW YORK, NY 10001
State of Incorp. DE
Fiscal Year End December 31
SIC 369 - Miscellaneous Electrical Machinery, Equipment, and Supplies (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 000153
Cash and cash equivalents 000153
Receivables 0  0  
Prepaid expense 000   
Total current assets: 100153
Noncurrent Assets
Property, plant and equipment 0    0
Long-term investments and receivables  160 0
Long-term investments  160 0
Intangible assets, net (including goodwill)   0111
Intangible assets, net (excluding goodwill)   0111
Regulated entity, other noncurrent assets    11 
Other noncurrent assets  00000
Other undisclosed noncurrent assets 21556 
Total noncurrent assets: 2311781
TOTAL ASSETS: 23118134
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 200110
Accrued liabilities 2     
Interest and dividends payable     0 
Other undisclosed accounts payable and accrued liabilities  00110
Debt      1
Due to related parties  21000
Other undisclosed current liabilities 0  000
Total current liabilities: 222212
Noncurrent Liabilities
Long-term debt and lease obligation    22 
Long-term debt, excluding current maturities    22 
Other undisclosed noncurrent liabilities 0    2
Total noncurrent liabilities: 0  222
Other undisclosed liabilities    00 
Total liabilities: 222433
Temporary equity, carrying amount  11111
Stockholders' equity
Stockholders' equity attributable to parent, including: (1)(0)839(1)
Common stock 111   
Treasury stock, value     (0) 
Additional paid in capital 686767646462
Accumulated deficit (69)(68)(60)(61)(55)(63)
Other undisclosed stockholders' equity attributable to parent (0)  111
Other undisclosed stockholders' equity 0   (0) 
Total stockholders' equity: (1)(0)839(1)
Other undisclosed liabilities and equity 1     
TOTAL LIABILITIES AND EQUITY: 23118134

Income statement (P&L) ($ in millions)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues 0 0001
Revenue, net 001
Cost of revenue
(Cost of Goods and Services Sold)
   (0)   
Gross profit: 0 (0)001
Operating expenses (1)(1)(2)(7)(6)(4)
Other undisclosed operating income   0 00
Operating loss: (1)(1)(2)(6)(6)(3)
Nonoperating income (expense) (0) 8   
Investment income, nonoperating (0) 8   
Interest and debt expense 0  0(1)(0)
Income (loss) from continuing operations before income taxes: (1)(1)6(6)(7)(4)
Other undisclosed income (loss) from continuing operations     15(0)
Income (loss) before gain (loss) on sale of properties: (1)(1)6(6)8(4)
Other undisclosed net loss (0)     
Net income (loss): (1)(1)6(6)8(4)
Other undisclosed net loss attributable to parent  (7)(4)   
Net income (loss) available to common stockholders, diluted: (1)(8)2(6)8(4)

Comprehensive Income ($ in millions)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss): (1)(1)6(6)8(4)
Comprehensive income (loss), net of tax, attributable to parent: (1)(1)6(6)8(4)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: